The external laryngeal nerve is responsible for innervating the cricothyroid muscle. If this nerve is injured, it can result in paralysis of the cricothyroid muscle, which is often referred to as the tuning fork of the larynx. This can cause hoarseness in the patient. However, over time, the other muscles will compensate for the paralysis, and the hoarseness will improve. It is important to note that the recurrent laryngeal nerve is responsible for innervating the rest of the muscles.

Anatomy of the Larynx

The larynx is located in the front of the neck, between the third and sixth cervical vertebrae. It is made up of several cartilaginous segments, including the paired arytenoid, corniculate, and cuneiform cartilages, as well as the single thyroid, cricoid, and epiglottic cartilages. The cricoid cartilage forms a complete ring. The laryngeal cavity extends from the laryngeal inlet to the inferior border of the cricoid cartilage and is divided into three parts: the laryngeal vestibule, the laryngeal ventricle, and the infraglottic cavity.

The vocal folds, also known as the true vocal cords, control sound production. They consist of the vocal ligament and the vocalis muscle, which is the most medial part of the thyroarytenoid muscle. The glottis is composed of the vocal folds, processes, and rima glottidis, which is the narrowest potential site within the larynx.

The larynx is also home to several muscles, including the posterior cricoarytenoid, lateral cricoarytenoid, thyroarytenoid, transverse and oblique arytenoids, vocalis, and cricothyroid muscles. These muscles are responsible for various actions, such as abducting or adducting the vocal folds and relaxing or tensing the vocal ligament.

The larynx receives its arterial supply from the laryngeal arteries, which are branches of the superior and inferior thyroid arteries. Venous drainage is via the superior and inferior laryngeal veins. Lymphatic drainage varies depending on the location within the larynx, with the vocal cords having no lymphatic drainage and the supraglottic and subglottic parts draining into different lymph nodes.

Overall, understanding the anatomy of the larynx is important for proper diagnosis and treatment of various conditions affecting this structure.

The chloride channel, specifically a cyclic-AMP regulated chloride channel, is the correct answer. Cystic fibrosis can be caused by various mutations, but they all affect the same gene, the cystic fibrosis transmembrane conductance regulator gene. This gene encodes a chloride channel that, when dysfunctional, results in increased viscosity of secretions and the development of cystic fibrosis.

Understanding Cystic Fibrosis

Cystic fibrosis is a genetic disorder that causes thickened secretions in the lungs and pancreas. It is an autosomal recessive condition that occurs due to a defect in the cystic fibrosis transmembrane conductance regulator gene (CFTR), which regulates a chloride channel. In the UK, 80% of CF cases are caused by delta F508 on chromosome 7, and the carrier rate is approximately 1 in 25.

CF patients are at risk of colonization by certain organisms, including Staphylococcus aureus, Pseudomonas aeruginosa, Burkholderia cepacia (previously known as Pseudomonas cepacia), and Aspergillus. These organisms can cause infections and exacerbate symptoms in CF patients. It is important for healthcare providers to monitor and manage these infections to prevent further complications.

Overall, understanding cystic fibrosis and its associated risks can help healthcare providers provide better care for patients with this condition.

When a patient presents with unilateral foul smelling discharge and deafness, it is important to consider the possibility of a cholesteatoma. If this is suspected during examination, it is necessary to refer the patient to an ENT specialist.

Pain is a common symptom of otitis media, while otitis externa typically causes inflammation and swelling of the ear canal. Impacted wax can lead to deafness, but it is unlikely to cause a discharge with a foul odor. It is also improbable for a woman of 45 years to have a foreign object in her ear for three weeks.

Understanding Cholesteatoma

Cholesteatoma is a benign growth of squamous epithelium that can cause damage to the skull base. It is most commonly found in individuals between the ages of 10 and 20 years old. Those born with a cleft palate are at a higher risk of developing cholesteatoma, with a 100-fold increase in risk.

The main symptoms of cholesteatoma include a persistent discharge with a foul odor and hearing loss. Other symptoms may occur depending on the extent of the growth, such as vertigo, facial nerve palsy, and cerebellopontine angle syndrome.

During otoscopy, a characteristic attic crust may be seen in the uppermost part of the eardrum.

Management of cholesteatoma involves referral to an ear, nose, and throat specialist for surgical removal. Early detection and treatment are important to prevent further damage to the skull base and surrounding structures.

In summary, cholesteatoma is a non-cancerous growth that can cause significant damage if left untreated. It is important to be aware of the symptoms and seek medical attention promptly if they occur.

The correct answer is 5600ml, which represents the total lung capacity. This value is obtained by adding the vital capacity, which is the maximum amount of air that can be breathed out after a deep inhalation, to the residual volume, which is the amount of air that remains in the lungs after a maximal exhalation. The vital capacity is composed of three volumes: the inspiratory reserve volume, the tidal volume, and the expiratory reserve volume. Other formulas are available to calculate different lung volumes, but they are not as commonly used.

Understanding Lung Volumes in Respiratory Physiology

In respiratory physiology, lung volumes can be measured to determine the amount of air that moves in and out of the lungs during breathing. The diagram above shows the different lung volumes that can be measured.

Tidal volume (TV) refers to the amount of air that is inspired or expired with each breath at rest. In males, the TV is 500ml while in females, it is 350ml.

Inspiratory reserve volume (IRV) is the maximum volume of air that can be inspired at the end of a normal tidal inspiration. The inspiratory capacity is the sum of TV and IRV. On the other hand, expiratory reserve volume (ERV) is the maximum volume of air that can be expired at the end of a normal tidal expiration.

Residual volume (RV) is the volume of air that remains in the lungs after maximal expiration. It increases with age and can be calculated by subtracting ERV from FRC. Speaking of FRC, it is the volume in the lungs at the end-expiratory position and is equal to the sum of ERV and RV.

Vital capacity (VC) is the maximum volume of air that can be expired after a maximal inspiration. It decreases with age and can be calculated by adding inspiratory capacity and ERV. Lastly, total lung capacity (TLC) is the sum of vital capacity and residual volume.

Physiological dead space (VD) is calculated by multiplying tidal volume by the difference between arterial carbon dioxide pressure (PaCO2) and end-tidal carbon dioxide pressure (PeCO2) and then dividing the result by PaCO2.

The expiratory reserve volume refers to the maximum amount of air that can be exhaled after a normal breath out. It is important to note that this volume can be reduced in conditions that limit lung expansion, such as obesity and ascites. Obesity, in particular, can cause a restrictive pattern on spirometry, where the FEV1/FVC ratio is ≥0.8. Other restrictive lung conditions include idiopathic pulmonary fibrosis, pleural effusion, ascites, and neuromuscular disorders that limit chest expansion. On the other hand, obstructive disorders like asthma and COPD lead to a FEV1/FVC ratio of <0.7, limiting the amount of air that can be exhaled in one second. It is essential to understand the different lung volumes and capacities, including inspiratory reserve volume, tidal volume, expiratory reserve volume, residual volume, inspiratory capacity, vital capacity, functional residual capacity, and total lung capacity. Understanding Lung Volumes in Respiratory Physiology In respiratory physiology, lung volumes can be measured to determine the amount of air that moves in and out of the lungs during breathing. The diagram above shows the different lung volumes that can be measured. Tidal volume (TV) refers to the amount of air that is inspired or expired with each breath at rest. In males, the TV is 500ml while in females, it is 350ml. Inspiratory reserve volume (IRV) is the maximum volume of air that can be inspired at the end of a normal tidal inspiration. The inspiratory capacity is the sum of TV and IRV. On the other hand, expiratory reserve volume (ERV) is the maximum volume of air that can be expired at the end of a normal tidal expiration. Residual volume (RV) is the volume of air that remains in the lungs after maximal expiration. It increases with age and can be calculated by subtracting ERV from FRC. Speaking of FRC, it is the volume in the lungs at the end-expiratory position and is equal to the sum of ERV and RV. Vital capacity (VC) is the maximum volume of air that can be expired after a maximal inspiration. It decreases with age and can be calculated by adding inspiratory capacity and ERV. Lastly, total lung capacity (TLC) is the sum of vital capacity and residual volume. Physiological dead space (VD) is calculated by multiplying tidal volume by the difference between arterial carbon dioxide pressure (PaCO2) and end-tidal carbon dioxide pressure (PeCO2) and then dividing the result by PaCO2.

The most crucial step to enhance the patient’s prognosis is to assist them in quitting smoking. While lung reduction surgery and long-term oxygen therapy may benefit certain patient groups, smoking cessation remains the top priority. Proper inhaler technique and adherence, as well as the use of home nebulizers, can provide symptomatic relief for the patient.

The National Institute for Health and Care Excellence (NICE) updated its guidelines on the management of chronic obstructive pulmonary disease (COPD) in 2018. The guidelines recommend general management strategies such as smoking cessation advice, annual influenzae vaccination, and one-off pneumococcal vaccination. Pulmonary rehabilitation is also recommended for patients who view themselves as functionally disabled by COPD.

Bronchodilator therapy is the first-line treatment for patients who remain breathless or have exacerbations despite using short-acting bronchodilators. The next step is determined by whether the patient has asthmatic features or features suggesting steroid responsiveness. NICE suggests several criteria to determine this, including a previous diagnosis of asthma or atopy, a higher blood eosinophil count, substantial variation in FEV1 over time, and substantial diurnal variation in peak expiratory flow.

If the patient does not have asthmatic features or features suggesting steroid responsiveness, a long-acting beta2-agonist (LABA) and long-acting muscarinic antagonist (LAMA) should be added. If the patient is already taking a short-acting muscarinic antagonist (SAMA), it should be discontinued and switched to a short-acting beta2-agonist (SABA). If the patient has asthmatic features or features suggesting steroid responsiveness, a LABA and inhaled corticosteroid (ICS) should be added. If the patient remains breathless or has exacerbations, triple therapy (LAMA + LABA + ICS) should be offered.

NICE only recommends theophylline after trials of short and long-acting bronchodilators or to people who cannot use inhaled therapy. Azithromycin prophylaxis is recommended in select patients who have optimised standard treatments and continue to have exacerbations. Mucolytics should be considered in patients with a chronic productive cough and continued if symptoms improve.

Cor pulmonale features include peripheral oedema, raised jugular venous pressure, systolic parasternal heave, and loud P2. Loop diuretics should be used for oedema, and long-term oxygen therapy should be considered. Smoking cessation, long-term oxygen therapy in eligible patients, and lung volume reduction surgery in selected patients may improve survival in patients with stable COPD. NICE does not recommend the use of ACE-inhibitors, calcium channel blockers, or alpha blockers

The respiratory alkalosis observed in the arterial blood gas results is most likely a result of hyperventilation, as indicated by the patient’s medical history.

Arterial Blood Gas Interpretation: A 5-Step Approach

Arterial blood gas interpretation is a crucial aspect of patient care, particularly in critical care settings. The Resuscitation Council (UK) recommends a 5-step approach to interpreting arterial blood gas results. The first step is to assess the patient’s overall condition. The second step is to determine if the patient is hypoxaemic, with a PaO2 on air of less than 10 kPa. The third step is to assess if the patient is acidaemic (pH <7.35) or alkalaemic (pH >7.45).

The fourth step is to evaluate the respiratory component of the arterial blood gas results. A PaCO2 level greater than 6.0 kPa suggests respiratory acidosis, while a PaCO2 level less than 4.7 kPa suggests respiratory alkalosis. The fifth step is to assess the metabolic component of the arterial blood gas results. A bicarbonate level less than 22 mmol/l or a base excess less than -2mmol/l suggests metabolic acidosis, while a bicarbonate level greater than 26 mmol/l or a base excess greater than +2mmol/l suggests metabolic alkalosis.

To remember the relationship between pH, PaCO2, and bicarbonate, the acronym ROME can be used. Respiratory acidosis or alkalosis is opposite to the pH level, while metabolic acidosis or alkalosis is equal to the pH level. This 5-step approach and the ROME acronym can aid healthcare professionals in interpreting arterial blood gas results accurately and efficiently.

The most likely cause of a pleural transudate is heart failure. This is due to the congestion of blood into the systemic venous circulation, which can result from long-standing COPD and increase in pulmonary vascular resistance leading to right-sided heart failure or cor pulmonale. Other options such as infective exacerbation of COPD or pulmonary edema secondary to heart failure are less likely to explain the clinical signs. Pleural exudate effusion secondary to cor pulmonale is also not the most appropriate answer as it would cause a transudate pleural effusion, not an exudate.

Understanding the Causes and Features of Pleural Effusion

Pleural effusion is a medical condition characterized by the accumulation of fluid in the pleural space, which is the area between the lungs and the chest wall. The causes of pleural effusion can be classified into two types: transudate and exudate. Transudate is characterized by a protein concentration of less than 30g/L and is commonly caused by heart failure, hypoalbuminemia, liver disease, and other conditions. On the other hand, exudate is characterized by a protein concentration of more than 30g/L and is commonly caused by infections, pneumonia, tuberculosis, and other conditions.

The symptoms of pleural effusion may include dyspnea, non-productive cough, and chest pain. Upon examination, patients may exhibit dullness to percussion, reduced breath sounds, and reduced chest expansion. It is important to identify the underlying cause of pleural effusion to determine the appropriate treatment plan. Early diagnosis and treatment can help prevent complications and improve the patient’s overall health.

Mastoiditis is a potential complication of acute otitis media, which can cause pain and swelling behind the ear over the mastoid bone. However, there is no evidence of tympanic membrane perforation, neurological symptoms or signs of meningitis or brain abscess, or facial nerve injury in this case.

Acute otitis media is a common condition in young children, often caused by bacterial infections following viral upper respiratory tract infections. Symptoms include ear pain, fever, and hearing loss, and diagnosis is based on criteria such as the presence of a middle ear effusion and inflammation of the tympanic membrane. Antibiotics may be prescribed in certain cases, and complications can include perforation of the tympanic membrane, hearing loss, and more serious conditions such as meningitis and brain abscess.

Neutrophils are typically elevated during an acute bacterial infection, while eosinophils are commonly elevated in response to parasitic infections and allergies. Lymphocytes tend to increase during acute viral infections and chronic inflammation. IgE levels are raised in cases of allergic asthma, malaria, and type 1 hypersensitivity reactions. Anti-CCP antibody is a diagnostic tool for Rheumatoid arthritis.

Pneumonia is a common condition that affects the alveoli of the lungs, usually caused by a bacterial infection. Other causes include viral and fungal infections. Streptococcus pneumoniae is the most common organism responsible for pneumonia, accounting for 80% of cases. Haemophilus influenzae is common in patients with COPD, while Staphylococcus aureus often occurs in patients following influenzae infection. Mycoplasma pneumoniae and Legionella pneumophilia are atypical pneumonias that present with dry cough and other atypical symptoms. Pneumocystis jiroveci is typically seen in patients with HIV. Idiopathic interstitial pneumonia is a group of non-infective causes of pneumonia.

Patients who develop pneumonia outside of the hospital have community-acquired pneumonia (CAP), while those who develop it within hospitals are said to have hospital-acquired pneumonia. Symptoms of pneumonia include cough, sputum, dyspnoea, chest pain, and fever. Signs of systemic inflammatory response, tachycardia, reduced oxygen saturations, and reduced breath sounds may also be present. Chest x-ray is used to diagnose pneumonia, with consolidation being the classical finding. Blood tests, such as full blood count, urea and electrolytes, and CRP, are also used to check for infection.

Patients with pneumonia require antibiotics to treat the underlying infection and supportive care, such as oxygen therapy and intravenous fluids. Risk stratification is done using a scoring system called CURB-65, which stands for confusion, respiration rate, blood pressure, age, and is used to determine the management of patients with community-acquired pneumonia. Home-based care is recommended for patients with a CRB65 score of 0, while hospital assessment is recommended for all other patients, particularly those with a CRB65 score of 2 or more. The CURB-65 score also correlates with an increased risk of mortality at 30 days.